West Palm Beach, FL – May 5, 2025 – Brain Power Clinics, a Florida-based healthcare provider specializing in cognitive conditions, announces the availability of TB006 for compassionate use in the treatment of Alzheimer’s disease. The new drug, currently in clinical trials, has shown promising early results in addressing memory loss and other symptoms associated with dementia.
Promising New Treatment for Alzheimer’s Disease
TB006, now available through Brain Power Clinics in Southern Florida, is designed to reduce inflammation in the brain by targeting galectin3, a protein linked to Alzheimer’s pathology. This mechanism may help dissolve the amyloid plaques and tau tangles that contribute to cognitive decline.
According to Dr. Arbella Sarkis, the chief investigator in the ongoing clinical trial, more than 400 patients have received TB006 with no reported side effects. “Approximately 70–80% of participants have experienced improvement in cognitive functions,” Dr. Sarkis stated.
Expert and Community Endorsements
Dr. Josh Helman, a Harvard-trained physician, has presented findings related to TB006 at A4M, a conference focused on anti-aging medical advancements. His presentation received strong interest due to the drug’s potential in helping individuals with early-stage dementia and memory impairment. Dr. Helman is the Chief Medical Officer of Brain Power Clinics. He has been treating patients with TB006 over the past year, and has seen excellent results in his patients.
Philanthropic support has also grown. Robert Buechner, Chairman of The BeEx Foundation and a long-time advocate for Alzheimer’s research, has backed the initiative. “For the first time in decades, we are seeing encouraging results that deserve wider attention,” Buechner said.
Access Remains Limited but Growing
Despite the positive data, TB006 is still in a controlled trial phase, limiting the number of healthcare providers who can offer it. Brain Power Clinics is currently one of the few centers in the U.S. administering the treatment.
Preliminary results shared by the drug’s manufacturer show that patients receiving TB006 demonstrated improved cognitive performance and reduced brain inflammation after three months of use compared to a placebo group. However, broader trials are needed to validate long-term outcomes.
Patients and families dealing with memory challenges or early signs of Alzheimer’s are encouraged to learn more about eligibility and access.
Text “Memory” to 728-203-3131 or visit www.BrainPowerClinics.com for more information.
About Brain Power Clinics
Brain Power Clinics, based in Palm Beach County, Florida, focuses on diagnosing and supporting individuals with dementia, cognitive decline, and memory-related issues. The clinic is dedicated to providing access to cutting-edge treatments under FDA oversight and compassionate use protocols.
Media ContactCompany Name: Brain Power ClinicsContact Person: Dr. Robert LoveEmail: Send EmailPhone: 728-203-3131Country: United StatesWebsite: http://www.brainpowerclinics.com/
